VHCP Management II’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

VHCP Management II’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3.21M	Hold	371,669	–	–	0.85%	13
2019 Q3	$2.29M	Buy	371,669 +185,700	+100%	+$1.5M	0.87%	17
2019 Q2	$3.09M	Hold	185,969	–	–	0.97%	17
2019 Q1	$3.11M	Hold	185,969	–	–	0.91%	15
2018 Q4	$2.13M	Buy	185,969 +86,660	+87%	+$1.75M	0.92%	16
2018 Q3	$3.97M	Buy	99,309 +12,999	+15%	+$370K	1.06%	18
2018 Q2	$2.44M	Buy	+86,310	New	+$1.91M	0.73%	16

Other funds holding MRNS

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VHCP Management II's MRNS Position: Q4 2019 in Review

VHCP Management II held its Marinus Pharmaceuticals, Inc (MRNS) position steady in Q4 2019 at 371,669 shares worth $3.21M. The position accounts for 0.85% of the portfolio, ranked #13.

VHCP Management II first reported a position in MRNS in Q2 2018 and has held it in 7 quarters since. The position peaked at $3.97M in Q3 2018. 79 funds tracked by Wall St. Rank hold MRNS as of Q4 2019.

VHCP Management II held 371,669 shares of Marinus Pharmaceuticals, Inc worth $3.21M as of Q4 2019.
VHCP Management II left its Marinus Pharmaceuticals, Inc share count unchanged in Q4 2019.
Marinus Pharmaceuticals, Inc made up 0.85% of VHCP Management II's portfolio in Q4 2019, its #13 holding.
VHCP Management II first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and has held it in 7 quarters since.
VHCP Management II's Marinus Pharmaceuticals, Inc position peaked at $3.97M in Q3 2018.
79 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.